| - GRCh37:
- Chr20:57876746
- GRCh38:
- Chr20:59301691
| EDN3 | H112N | Waardenburg syndrome type 4B | Likely pathogenic (Nov 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr20:57876744
- GRCh38:
- Chr20:59301689
| EDN3 | C111F | Waardenburg syndrome type 4B | Uncertain significance (Jul 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr20:57899485
- GRCh38:
- Chr20:59324430
| EDN3 | R230C, R216C | Hirschsprung disease, susceptibility to, 4, Waardenburg syndrome type 4B, not provided, Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Apr 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:57896132
- GRCh38:
- Chr20:59321077
| EDN3 | | not specified, Hirschsprung disease, susceptibility to, 4, Waardenburg syndrome type 4B, not provided, Hirschsprung disease, susceptibility to, 4 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:57876705
- GRCh38:
- Chr20:59301650
| EDN3 | T98K | Waardenburg syndrome type 4B, Hirschsprung disease, susceptibility to, 4 | Conflicting interpretations of pathogenicity (Feb 17, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:57875910
- GRCh38:
- Chr20:59300855
| EDN3 | S15A | not provided, Hirschsprung disease, susceptibility to, 4, Waardenburg syndrome type 4B, Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Feb 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:57897443-57897444
- GRCh38:
- Chr20:59322388-59322389
| EDN3 | T189fs | Hirschsprung Disease, Dominant, not specified, Waardenburg syndrome type 4B, not provided | Benign/Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:57876689
- GRCh38:
- Chr20:59301634
| EDN3 | R93G | Waardenburg syndrome type 4B | Pathogenic (Jul 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr20:57876747
- GRCh38:
- Chr20:59301692
| EDN3 | H112R | Waardenburg syndrome type 4B | Pathogenic (Oct 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr20:57896213
- GRCh38:
- Chr20:59321158
| EDN3 | C169* | Waardenburg syndrome type 4B | Pathogenic (Mar 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr20:57899467
- GRCh38:
- Chr20:59324412
| EDN3 | A224T, A210T | not specified, not provided, Waardenburg syndrome type 4B
| Likely benign (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:57896182
- GRCh38:
- Chr20:59321127
| EDN3 | C159F | Waardenburg syndrome type 4B | Pathogenic (Apr 1, 1996) | no assertion criteria provided |
| - GRCh37:
- Chr20:57876674-57876675
- GRCh38:
- Chr20:59301619-59301620
| EDN3 | A88fs | Waardenburg syndrome type 4B | Pathogenic (Apr 1, 1996) | no assertion criteria provided |